StreetInsider.com News Articles

AURORA SPINE CORPORATION ANNOUNCES AMENDMENT TO LOAN FROM INSIDER

Wed, 04 Mar 2026 17:01:00 +0000

Carlsbad, California, March 04, 2026 (GLOBE NEWSWIRE) -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF) announced today this it has amended an existing loan (the "Loan") in the principal amount of US$1,600,000 plus accrued and unpaid interest in the amount of US$1,249,500 from an insider of the Company. The Company has been using the Loan proceeds for general corporate purposes.

The Loan, evidenced by a promissory note (the "Note") bears interest at 9% per annum. The Amendment reduces the interest rate to 4.5% per annum effective January

AURORA SPINE CORPORATION ANNOUNCES AMENDMENT TO LOAN FROM INSIDER

Wed, 04 Mar 2026 17:01:00 +0000

The Loan, evidenced by a promissory note (the "Note") bears interest at 9% per annum. The Amendment reduces the interest rate to 4.5% per annum effective January

AURORA SPINE CORPORATION ANNOUNCES AMENDMENT TO LOAN FROM INSIDER

Wed, 04 Mar 2026 17:01:00 +0000

The Loan, evidenced by a promissory note (the "Note") bears interest at 9% per annum. The Amendment reduces the interest rate to 4.5% per annum effective January

AURORA SPINE CORPORATION ANNOUNCES AMENDMENT TO LOAN FROM INSIDER

Wed, 04 Mar 2026 17:01:00 +0000

The Loan, evidenced by a promissory note (the "Note") bears interest at 9% per annum. The Amendment reduces the interest rate to 4.5% per annum effective January

AURORA SPINE CORPORATION ANNOUNCES AMENDMENT TO LOAN FROM INSIDER

Wed, 04 Mar 2026 17:01:00 +0000

The Loan, evidenced by a promissory note (the "Note") bears interest at 9% per annum. The Amendment reduces the interest rate to 4.5% per annum effective January

AURORA SPINE CORPORATION ANNOUNCES AMENDMENT TO LOAN FROM INSIDER

Wed, 04 Mar 2026 17:01:00 +0000

The Loan, evidenced by a promissory note (the "Note") bears interest at 9% per annum. The Amendment reduces the interest rate to 4.5% per annum effective January

AURORA SPINE CORPORATION ANNOUNCES AMENDMENT TO LOAN FROM INSIDER

Wed, 04 Mar 2026 17:01:00 +0000

The Loan, evidenced by a promissory note (the "Note") bears interest at 9% per annum. The Amendment reduces the interest rate to 4.5% per annum effective January

AURORA SPINE CORPORATION ANNOUNCES AMENDMENT TO LOAN FROM INSIDER

Wed, 04 Mar 2026 17:01:00 +0000

The Loan, evidenced by a promissory note (the "Note") bears interest at 9% per annum. The Amendment reduces the interest rate to 4.5% per annum effective January

AURORA SPINE CORPORATION ANNOUNCES AMENDMENT TO LOAN FROM INSIDER

Wed, 04 Mar 2026 17:01:00 +0000

The Loan, evidenced by a promissory note (the "Note") bears interest at 9% per annum. The Amendment reduces the interest rate to 4.5% per annum effective January

AURORA SPINE CORPORATION ANNOUNCES AMENDMENT TO LOAN FROM INSIDER

Wed, 04 Mar 2026 17:01:00 +0000

The Loan, evidenced by a promissory note (the "Note") bears interest at 9% per annum. The Amendment reduces the interest rate to 4.5% per annum effective January

AURORA SPINE CORPORATION ANNOUNCES AMENDMENT TO LOAN FROM INSIDER

Wed, 04 Mar 2026 17:01:00 +0000

The Loan, evidenced by a promissory note (the "Note") bears interest at 9% per annum. The Amendment reduces the interest rate to 4.5% per annum effective January

AURORA SPINE CORPORATION ANNOUNCES AMENDMENT TO LOAN FROM INSIDER

Wed, 04 Mar 2026 17:01:00 +0000

The Loan, evidenced by a promissory note (the "Note") bears interest at 9% per annum. The Amendment reduces the interest rate to 4.5% per annum effective January

AURORA SPINE CORPORATION ANNOUNCES AMENDMENT TO LOAN FROM INSIDER

Wed, 04 Mar 2026 17:01:00 +0000

The Loan, evidenced by a promissory note (the "Note") bears interest at 9% per annum. The Amendment reduces the interest rate to 4.5% per annum effective January

AURORA SPINE CORPORATION ANNOUNCES AMENDMENT TO LOAN FROM INSIDER

Wed, 04 Mar 2026 17:01:00 +0000

The Loan, evidenced by a promissory note (the "Note") bears interest at 9% per annum. The Amendment reduces the interest rate to 4.5% per annum effective January

Aurora Spine Announces Issuance of Two U.S. Patents

Thu, 08 Jan 2026 07:15:00 +0000

CARLSBAD, CA, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in minimally invasive spine and interventional pain solutions, today announced the issuance of two independent U.S. patents by the US Patent and Trademark Office. The issuance of these patents strengthens the company’s intellectual property portfolio and reinforces its long-term innovation strategy across multiple spinal implant platforms.

New Issued U.S. Patent for the ZIP™ Implant Family

The first patent issued was No. 12,478,411 B2, titled Spinal Implant for Motion Preservation

Aurora Spine Announces Issuance of Two U.S. Patents

Thu, 08 Jan 2026 07:15:00 +0000

CARLSBAD, CA, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in minimally invasive spine and interventional pain solutions, today announced the issuance of two independent U.S. patents by the US Patent and Trademark Office. The issuance of these patents strengthens the company’s intellectual property portfolio and reinforces its long-term innovation strategy across multiple spinal implant platforms.

New Issued U.S. Patent for the ZIP™ Implant Family

The first patent issued was No. 12,478,411 B2, titled Spinal Implant for Motion Preservation

Aurora Spine Announces Issuance of Two U.S. Patents

Thu, 08 Jan 2026 07:15:00 +0000

CARLSBAD, CA, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in minimally invasive spine and interventional pain solutions, today announced the issuance of two independent U.S. patents by the US Patent and Trademark Office. The issuance of these patents strengthens the company’s intellectual property portfolio and reinforces its long-term innovation strategy across multiple spinal implant platforms.

New Issued U.S. Patent for the ZIP™ Implant Family

The first patent issued was No. 12,478,411 B2, titled Spinal Implant for Motion Preservation

Aurora Spine Announces Issuance of Two U.S. Patents

Thu, 08 Jan 2026 07:15:00 +0000

CARLSBAD, CA, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in minimally invasive spine and interventional pain solutions, today announced the issuance of two independent U.S. patents by the US Patent and Trademark Office. The issuance of these patents strengthens the company’s intellectual property portfolio and reinforces its long-term innovation strategy across multiple spinal implant platforms.

New Issued U.S. Patent for the ZIP™ Implant Family

The first patent issued was No. 12,478,411 B2, titled Spinal Implant for Motion Preservation

Aurora Spine Announces Issuance of Two U.S. Patents

Thu, 08 Jan 2026 07:15:00 +0000

CARLSBAD, CA, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in minimally invasive spine and interventional pain solutions, today announced the issuance of two independent U.S. patents by the US Patent and Trademark Office. The issuance of these patents strengthens the company’s intellectual property portfolio and reinforces its long-term innovation strategy across multiple spinal implant platforms.

New Issued U.S. Patent for the ZIP™ Implant Family

The first patent issued was No. 12,478,411 B2, titled Spinal Implant for Motion Preservation

Aurora Spine Announces Issuance of Two U.S. Patents

Thu, 08 Jan 2026 07:15:00 +0000

CARLSBAD, CA, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in minimally invasive spine and interventional pain solutions, today announced the issuance of two independent U.S. patents by the US Patent and Trademark Office. The issuance of these patents strengthens the company’s intellectual property portfolio and reinforces its long-term innovation strategy across multiple spinal implant platforms.

New Issued U.S. Patent for the ZIP™ Implant Family

The first patent issued was No. 12,478,411 B2, titled Spinal Implant for Motion Preservation

Aurora Spine Announces Issuance of Two U.S. Patents

Thu, 08 Jan 2026 07:15:00 +0000

CARLSBAD, CA, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in minimally invasive spine and interventional pain solutions, today announced the issuance of two independent U.S. patents by the US Patent and Trademark Office. The issuance of these patents strengthens the company’s intellectual property portfolio and reinforces its long-term innovation strategy across multiple spinal implant platforms.

New Issued U.S. Patent for the ZIP™ Implant Family

The first patent issued was No. 12,478,411 B2, titled Spinal Implant for Motion Preservation

Aurora Spine Announces Issuance of Two U.S. Patents

Thu, 08 Jan 2026 07:15:00 +0000

CARLSBAD, CA, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in minimally invasive spine and interventional pain solutions, today announced the issuance of two independent U.S. patents by the US Patent and Trademark Office. The issuance of these patents strengthens the company’s intellectual property portfolio and reinforces its long-term innovation strategy across multiple spinal implant platforms.

New Issued U.S. Patent for the ZIP™ Implant Family

The first patent issued was No. 12,478,411 B2, titled Spinal Implant for Motion Preservation

Aurora Spine Announces Issuance of Two U.S. Patents

Thu, 08 Jan 2026 07:15:00 +0000

CARLSBAD, CA, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in minimally invasive spine and interventional pain solutions, today announced the issuance of two independent U.S. patents by the US Patent and Trademark Office. The issuance of these patents strengthens the company’s intellectual property portfolio and reinforces its long-term innovation strategy across multiple spinal implant platforms.

New Issued U.S. Patent for the ZIP™ Implant Family

The first patent issued was No. 12,478,411 B2, titled Spinal Implant for Motion Preservation

Aurora Spine Announces Issuance of Two U.S. Patents

Thu, 08 Jan 2026 07:15:00 +0000

CARLSBAD, CA, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in minimally invasive spine and interventional pain solutions, today announced the issuance of two independent U.S. patents by the US Patent and Trademark Office. The issuance of these patents strengthens the company’s intellectual property portfolio and reinforces its long-term innovation strategy across multiple spinal implant platforms.

New Issued U.S. Patent for the ZIP™ Implant Family

The first patent issued was No. 12,478,411 B2, titled Spinal Implant for Motion Preservation

Aurora Spine Corporation Announces Participation at the North American Spine Society Annual Meeting

Wed, 12 Nov 2025 18:03:00 +0000

Company to Showcase Cutting-Edge Innovations at Booth #1622

CARLSBAD, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a leader in the development of groundbreaking medical devices for spinal surgery, today announced its participation at the 2025 North American Spine Society ("NASS") Annual Meeting. The event will take place from November 14-16, 2025, at the Colorado Convention Center, in Denver, Colorado. Aurora Spine will be exhibiting at Booth #1622.

The North American Spine Society is a global multidisciplinary medical society